Literature DB >> 11040946

Screening of the entire coding region of p53 in low grade lymphoproliferative disorders.

T J Bromidge1, D J Howe.   

Abstract

This report details a rapid method for screening the entire p53 coding region (exons 2-11). This method, based on the non-isotopic RNase cleavage assay, uses novel primer sequences and an adaptation of the MutationScreener method. A mutation in 20% of the sample was easily detectable by this method, whereas mutations below 50% were undetectable using the original method. Alterations to the wild-type p53 mRNA sequence were found in nine of the 130 patients with low grade lymphoproliferative disorders screened, and this was confirmed by DNA sequencing in eight of eight samples. The method is a simple and reliable technique for screening for p53 mutations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11040946      PMCID: PMC1186973          DOI: 10.1136/mp.53.4.216

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  6 in total

1.  NIRCA: a rapid robust method for screening for unknown point mutations.

Authors:  M M Goldrick; G R Kimball; Q Liu; L A Martin; S S Sommer; J Y Tseng
Journal:  Biotechniques       Date:  1996-07       Impact factor: 1.993

2.  p53 abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis.

Authors:  D Lens; M J Dyer; J M Garcia-Marco; P J De Schouwer; R A Hamoudi; D Jones; N Farahat; E Matutes; D Catovsky
Journal:  Br J Haematol       Date:  1997-12       Impact factor: 6.998

3.  Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium.

Authors:  G S Firestein; F Echeverri; M Yeo; N J Zvaifler; D R Green
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

4.  Nucleotide sequence polymorphism in a hotspot mutation region of the p53 gene.

Authors:  G R Mazars; P Jeanteur; H T Lynch; G Lenoir; C Theillet
Journal:  Oncogene       Date:  1992-04       Impact factor: 9.867

Review 5.  The clinical significance of mutations of the P53 tumour suppressor gene in haematological malignancies.

Authors:  C Preudhomme; P Fenaux
Journal:  Br J Haematol       Date:  1997-09       Impact factor: 6.998

6.  Mutations in the p53 gene are not limited to classic 'hot spots' and are not predictive of p53 protein expression in high-grade non-Hodgkin's lymphoma.

Authors:  S Kocialkowski; F Pezzella; H Morrison; M Jones; S Laha; A L Harris; D Y Mason; K C Gatter
Journal:  Br J Haematol       Date:  1995-01       Impact factor: 6.998

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.